✦ LIBER ✦

1372 EFFICACY OF THE β3-ADRENOCEPTOR AGONIST MIRABEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER (OAB) IN PATIENTS WITH INCONTINENCE: PROSPECTIVE POOLED ANALYSIS OF 3 RANDOMIZED PHASE 3 TRIALS

✍ Scribed by Nitti, Victor; Barkin, Jack; Van Kerrebroeck, Philip; Jeffrey, Frankel; Mitcheson, David; Blauwet, Mary Beth; Siddiqui, Emad; Martin, Nancy

Book ID: 122614990
Publisher: Lippincott Williams and Wilkins
Year: 2013
Tongue: English
Weight: 213 KB
Volume: 189
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2013.02.2726

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1957 TOLERABILITY OF THE Β3-ADRENOCEPTOR

1957 TOLERABILITY OF THE Β3-ADRENOCEPTOR AGONIST MIRABEGRON: A PROSPECTIVE POOLED ANALYSIS OF 3 RANDOMIZED PHASE 3 TRIALS

✍ Nitti, Victor; Chapple, Christopher; Auerbach, Stephen M; Walters, Carien; Blauw 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 246 KB

Efficacy and Tolerability of Mirabegron,

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial

✍ Vik Khullar; Gerard Amarenco; Javier C. Angulo; Javier Cambronero; Kjetil Høye; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 827 KB

Efficacy and Tolerability of Mirabegron,

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial

✍ Rovner, E.S. 📂 Article 📅 2013 🏛 Elsevier Science ⚖ 51 KB

Re: Efficacy and Tolerability of Mirabeg

Re: Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European-Australian Phase 3 Trial

✍ Wein, Alan J. 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 117 KB

Onset of action of the β3-adrenoceptor a

Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

✍ Chapple, Christopher R.; Nitti, Victor W.; Khullar, Vik; Wyndaele, Jean Jacques; 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 360 KB

401 The incidence of antimuscarinic-asso

401 The incidence of antimuscarinic-associated side effects in overactive bladder (OAB) patients treated with mirabegron: Results of a pooled analysis of 3 randomised phase 3 trials

✍ Nitti, V.; Chapple, C.R.; Amarenco, G.; Radziszewski, P.; Angulo, J.; Blauwet, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 294 KB